Cargando…
Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil
BACKGROUND: Eradication of hepatitis C virus (HCV) using direct-acting agents (DAA) has been associated with a financial burden to health authorities worldwide. We aimed to evaluate the guideline-based treatment costs by DAAs from the perspective of the Brazilian Ministry of Health (BMoH). METHODS:...
Autores principales: | Perazzo, Hugo, Jorge, Marcelino Jose, Silva, Julio Castro, Avellar, Alexandre Monken, Silva, Patrícia Santos, Romero, Carmen, Veloso, Valdilea Gonçalves, Mujica-Mota, Ruben, Anderson, Rob, Hyde, Chris, Castro, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701370/ https://www.ncbi.nlm.nih.gov/pubmed/29169329 http://dx.doi.org/10.1186/s12876-017-0676-8 |
Ejemplares similares
-
Hepatitis of unknown etiology in children in Brazil: A new challenge or the usual scenario ?
por: Castro, Rodolfo, et al.
Publicado: (2022) -
Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography
por: Perazzo, Hugo, et al.
Publicado: (2015) -
Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
por: Castro, Rodolfo, et al.
Publicado: (2015) -
COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil
por: Castro, Rodolfo, et al.
Publicado: (2020) -
Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis
por: Castro, Rodolfo, et al.
Publicado: (2020)